Nanoparticles for imaging, sensing, and therapeutic intervention

ACS Nano

Volumn 8, Issue 4, 2014, Pages 3107-3122

  Bogart, Lara K ^a   Pourroy, Genevieve ^b   Murphy, Catherine J ^c   Puntes, Victor ^d   Pellegrino, Teresa ^e   Rosenblum, Daniel ^f   Peer, Dan ^f   Lévy, Raphaël ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d CSIC   (Spain)

^e Instituto Italiano di Tecnologia   (Italy)

^f TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR IMAGING;

ANIMAL MODEL; BIOLOGICAL MEDIA; HYBRID NANOMATERIALS; KNOWLEDGE GAPS; NEW MODALITY; PHYSICOCHEMICAL PROPERTY; SURFACE DESIGN; THERAPEUTIC INTERVENTION;

NANOPARTICLES;

BIOMATERIAL; NANOPARTICLE;

ANIMAL; CHEMISTRY; DIAGNOSTIC USE; HUMAN; METABOLISM; MOLECULAR IMAGING; NANOMEDICINE; PROCEDURES;

ANIMALS; BIOCOMPATIBLE MATERIALS; HUMANS; MOLECULAR IMAGING; NANOMEDICINE; NANOPARTICLES;

EID: 84899429837     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn500962q     Document Type: Article

References (134)

1. Neel, L. Les Proprietes Magnetiques du Sesquioxyde de Fer Rhomboedrique C. R. Hebd. Seances Acad. Sci. 1949, 228, 64-66
2. Bean, C. P.; Livingston, J. D. Superparamagnetism J. Appl. Phys. 1959, 30, 120S-129S
3. Pankhurst, Q. A.; Connolly, J.; Jones, S. K.; Dobson, J. Applications of Magnetic Nanoparticles in Biomedicine J. Phys. D: Appl. Phys. 2003, 36, R167-R181
4. Pankhurst, Q. A.; Thanh, N. T. K.; Jones, S. K.; Dobson, J. Progress in Applications of Magnetic Nanoparticles in Biomedicine J. Phys. D: Appl. Phys. 2009, 42, 224001
5. Cullity, B. D. Introduction to Magnetic Materials; Addison-Wesley: Reading, MA, 1972.
6. Gilchrist, R. K.; Medal, R.; Shorey, W. D.; Hanselman, R. C.; Parrott, J. C.; Taylor, C. B. Selective Inductive Heating of Lymph Nodes Ann. Surg. 1957, 146, 596-606
7. Gordon, R. T.; Hines, J. R.; Gordon, D. Intracellular Hyperthermia-Biophysical Approach to Cancer Treatment via Intracellular Temperature and Biophysical AlterationsS Med. Hypotheses 1979, 5, 83-102
8. Mejias, R.; Gutierrez, L.; Salas, G.; Perez-Yague, S.; Zotes, T. M.; Lazaro, F. J.; Morales, M. P.; Barber, D. F. Long Term Biotransformation and Toxicity of Dimercaptosuccinic Acid-Coated Magnetic Nanoparticles Support Their Use in Biomedical Applications J. Controlled Release 2013, 171, 225-233
9. Levy, M.; Lagarde, F.; Maraloiu, V.-A.; Blanchin, M.-G.; Gendron, F.; Wilhelm, C.; Gazeau, F. Degradability of Superparamagnetic Nanoparticles in a Model of Intracellular Environment: Follow-Up of Magnetic, Structural and Chemical Properties Nanotechnology 2010, 21, 395103
10. Levy, M.; Luciani, N.; Alloyeau, D.; Elgrabli, D.; Deveaux, V.; Pechoux, C.; Chat, S.; Wang, G.; Vats, N.; Gendron, F. et al. Long Term In Vivo Biotransformation of Iron Oxide Nanoparticles Biomaterials 2011, 32, 3988-3999
11. Chantrell, R. W.; Popplewell, J.; Charles, S. W. Measurements of Particle-Size Distribution Parameters in Ferrofluids IEEE Trans. Magn. 1978, 14, 975-977
12. Chen, D. X.; Sanchez, A.; Taboada, E.; Roig, A.; Sun, N.; Gu, H. C. Size Determination of Superparamagnetic Nanoparticles from Magnetization Curve J. Appl. Phys. 2009, 105, 083924
13. El-Hilo, M. Nano-Particle Magnetism with a Dispersion of Particle Sizes J. Appl. Phys. 2012, 112, 103915
14. Elmore, W. C. The Magnetization of Ferromagnetic Colloids Phys. Rev. 1938, 54, 1092-1095
15. Levy, M.; Gazeau, F.; Bacri, J.-C.; Wilhelm, C.; Devaud, M. Modeling Magnetic Nanoparticle Dipole-Dipole Interactions Inside Living Cells Phys. Rev. B 2011, 84, 075480
16. Levy, M.; Wilhelm, C.; Luciani, N.; Deveaux, V.; Gendron, F.; Luciani, A.; Devaud, M.; Gazeau, F. Nanomagnetism Reveals the Intracellular Clustering of Iron Oxide Nanoparticles in the Organism Nanoscale 2011, 3, 4402-4410
17. Gossuin, Y.; Gillis, P.; Hocq, A.; Vuong, Q. L.; Roch, A. Magnetic Resonance Relaxation Properties of Superparamagnetic Particles Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2009, 1, 299-310
18. Klug, G.; Kampf, T.; Bloemer, S.; Bremicker, J.; Ziener, C. H.; Heymer, A.; Gbureck, U.; Rommel, E.; Noeth, U.; Schenk, W. A. et al. Intracellular and Extracellular T-1 and T-2 Relaxivities of Magneto-Optical Nanoparticles at Experimental High Fields Magn. Reson. Med. 2010, 64, 1607-1615
19. Hergt, R.; Dutz, S.; Muller, R.; Zeisberger, M. Magnetic Particle Hyperthermia: Nanoparticle Magnetism and Materials Development for Cancer Therapy J. Phys.: Condens. Matter 2006, 18, S2919-S2934
20. Dennis, C. L.; Ivkov, R. Physics of Heat Generation Using Magnetic Nanoparticles for Hyperthermia Int. J. Hyperthermia 2013, 29, 715-729
21. Dutz, S.; Hergt, R. Magnetic Nanoparticle Heating and Heat Transfer on a Microscale: Basic Principles, Realities and Physical Limitations of Hyperthermia for Tumour Therapy Int. J. Hyperthermia 2013, 29, 790-800
22. Rosensweig, R. E. Heating Magnetic Fluid with Alternating Magnetic Field J. Magn. Magn. Mater. 2002, 252, 370-374
23. Vallejo-Fernandez, G.; Whear, O.; Roca, A. G.; Hussain, S.; Timmis, J.; Patel, V.; O'Grady, K. Mechanisms of Hyperthermia in Magnetic Nanoparticles J. Phys. D: Appl. Phys. 2013, 46, 312001
24. Carney, R. P.; DeVries, G. A.; Dubois, C.; Kim, H.; Kim, J. Y.; Singh, C.; Ghorai, P. K.; Tracy, J. B.; Stiles, R. L.; Murray, R. W. et al. Size Limitations for the Formation of Ordered Striped Nanoparticles J. Am. Chem. Soc. 2008, 130, 798-799
25. Pons-Siepermann, I. C.; Glotzer, S. C. Design of Patchy Particles Using Quaternary Self-Assembled Monolayers ACS Nano 2012, 6, 3919-3924
26. Zhang, Z. L.; Glotzer, S. C. Self-Assembly of Patchy Particles Nano Lett. 2004, 4, 1407-1413
27. Stirling, J.; Woolley, R. A. J.; Moriarty, P. Scanning Probe Image Wizard: A Toolbox for Automated Scanning Probe Microscopy Data Analysis Rev. Sci. Instrum. 2013, 84, 113701
28. Centrone, A.; Penzo, E.; Sharma, M.; Myerson, J. W.; Jackson, A. M.; Marzari, N.; Stellacci, F. The Role of Nanostructure in the Wetting Behavior of Mixed-Monolayer-Protected Metal Nanoparticles Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 9886-9891
29. Cesbron, Y.; Shaw, C. P.; Birchall, J. P.; Free, P.; Levy, R. Stripy Nanoparticles Revisited Small 2012, 8, 3714-3719
30. Fishler, R.; Artzy-Schnirman, A.; Peer, E.; Wolchinsky, R.; Brener, R.; Waks, T.; Eshhar, Z.; Reiter, Y.; Sivan, U. Mixed Alkanethiol Monolayers on Submicrometric Gold Patterns: A Controlled Platform for Studying Cell-Ligand Interactions Nano Lett. 2012, 12, 4992-4996
31. Harkness, K. M.; Balinski, A.; McLean, J. A.; Cliffel, D. E. Nanoscale Phase Segregation of Mixed Thiolates on Gold Nanoparticles Angew. Chem., Int. Ed. 2011, 50, 10554-10559
32. Jackson, A. M.; Myerson, J. W.; Stellacci, F. Spontaneous Assembly of Subnanometre-Ordered Domains in the Ligand Shell of Monolayer-Protected Nanoparticles Nat. Mater. 2004, 3, 330-336
33. Jiang, S.; Chen, Q.; Tripathy, M.; Luijten, E.; Schweizer, K. S.; Granick, S. Janus Particle Synthesis and Assembly Adv. Mater. 2010, 22, 1060-1071
34. Verma, A.; Uzun, O.; Hu, Y.; Hu, Y.; Han, H.-S.; Watson, N.; Chen, S.; Irvine, D. J.; Stellacci, F. Surface-Structure-Regulated Cell-Membrane Penetration by Monolayer-Protected Nanoparticles Nat. Mater. 2008, 7, 588-595
35. Yang, J. A.; Murphy, C. J. Evidence for Patchy Lipid Layers on Gold Nanoparticle Surfaces Langmuir 2012, 28, 5404-5416
36. Yu, M.; Stellacci, F. Response to "Stripy Nanoparticles Revisited" Small 2012, 8, 3720-3726
37. Abraham, S.; Unsworth, L. D. Multi-functional Initiator and Poly(carboxybetaine methacrylamides) for Building Biocompatible Surfaces Using "Nitroxide Mediated Free Radical Polymerization" Strategies J. Polym. Sci., Polym. Chem. 2011, 49, 1051-1060
38. Alconcel, S. N. S.; Baas, A. S.; Maynard, H. D. FDA-Approved Poly(ethylene glycol)-Protein Conjugate Drugs Polym. Chem. 2011, 2, 1442-1448
39. Gref, R.; Luck, M.; Quellec, P.; Marchand, M.; Dellacherie, E.; Harnisch, S.; Blunk, T.; Muller, R. H. 'Stealth' Corona-Core Nanoparticles Surface Modified by Polyethylene Glycol (PEG): Influences of the Corona (PEG Chain Length and Surface Density) and of the Core Composition on Phagocytic Uptake and Plasma Protein Adsorption Colloids Surf., B 2000, 18, 301-313
40. Muro, E.; Pons, T.; Lequeux, N.; Fragola, A.; Sanson, N.; Lenkei, Z.; Dubertret, B. Small and Stable Sulfobetaine Zwitterionic Quantum Dots for Functional Live-Cell Imaging J. Am. Chem. Soc. 2010, 132, 4556-4557
41. Sawhney, A. S.; Hubbell, J. A. Poly(ethylene oxide)-Graft-Poly(l -lysine) Copolymers To Enhance the Biocompatibility of Poly(l -lysine)-Alginate Microcapsule Membranes Biomaterials 1992, 13, 863-870
42. Zhang, L.; Cao, Z.; Bai, T.; Carr, L.; Ella-Menye, J.-R.; Irvin, C.; Ratner, B. D.; Jiang, S. Zwitterionic Hydrogels Implanted in Mice Resist the Foreign-Body Reaction Nat. Biotechnol. 2013, 31, 553-556
43. Wang, W.; Wei, Q.-Q.; Wang, J.; Wang, B.-C.; Zhang, S.-h.; Yuan, Z. Role of Thiol-Containing Polyethylene Glycol (Thiol-PEG) in the Modification Process of Gold Nanoparticles (AuNPs): Stabilizer or Coagulant? J. Colloid Interface Sci. 2013, 404, 223-229
44. Andersen, A. J.; Windschiegl, B.; Ilbasmis-Tamer, S.; Degim, I. T.; Hunter, A. C.; Andresen, T. L.; Moghimi, S. M. Complement Activation by PEG-Functionalized Multi-walled Carbon Nanotubes Is Independent of PEG Molecular Mass and Surface Density Nanomedicine 2013, 9, 469-473
45. Bradley, A. J.; Test, S. T.; Murad, K. L.; Mitsuyoshi, J.; Scott, M. D. Interactions of IgM ABO Antibodies and Complement with Methoxy-PEG-Modified Human RBCs Transfusion 2001, 41, 1225-1233
46. Sroda, K.; Rydlewski, J.; Langner, M.; Kozubek, A.; Grzybek, M.; Sikorski, A. F. Repeated Injections of PEG-PE Liposomes Generate Anti-PEG Antibodies Cell. Mol. Biol. Lett. 2005, 10, 37-47
47. Szebeni, J.; Baranyi, L.; Savay, S.; Milosevits, J.; Bunger, R.; Laverman, P.; Metselaar, J. M.; Storm, G.; Chanan-Khan, A.; Liebes, L. et al. Role of Complement Activation in Hypersensitivity Reactions to Doxil and HYNICPEG Liposomes: Experimental and Clinical Studies J. Liposome Res. 2002, 12, 165-172
48. van den Hoven, J. M.; Nemes, R.; Metselaar, J. M.; Nuijen, B.; Beijnen, J. H.; Storm, G.; Szebeni, J. Complement Activation by PEGylated Liposomes Containing Prednisolone Eur. J. Pharm. Sci. 2013, 49, 265-271
49. Aggarwal, P.; Hall, J. B.; McLeland, C. B.; Dobrovolskaia, M. A.; McNeil, S. E. Nanoparticle Interaction with Plasma Proteins as It Relates to Particle Biodistribution, Biocompatibility and Therapeutic Efficacy Adv. Drug Delivery Rev. 2009, 61, 428-437
50. Casals, E.; Pfaller, T.; Duschl, A.; Oostingh, G. J.; Puntes, V. Time Evolution of the Nanoparticle Protein Corona ACS Nano 2010, 4, 3623-3632
51. Faunce, T. A.; White, J.; Matthael, K. I. Integrated Research into the Nanoparticle-Protein Corona: A New Focus for Safe, Sustainable and Equitable Development of Nanomedicines Nanomedicine 2008, 3, 859-866
52. Cho, E. C.; Zhang, Q.; Xia, Y. N. The Effect of Sedimentation and Diffusion on Cellular Uptake of Gold Nanoparticles Nat. Nanotechnol. 2011, 6, 385-391
53. Oostingh, G. J.; Casals, E.; Italiani, P.; Colognato, R.; Stritzinger, R.; Ponti, J.; Pfaller, T.; Kohl, Y.; Ooms, D.; Favilli, F. et al. Problems and Challenges in the Development and Validation of Human Cell-Based Assays To Determine Nanoparticle-Induced Immunomodulatory Effects Part. Fibre Toxicol. 2011, 8, 8
54. Casals, E.; Vazquez-Campos, S.; Bastus, N. G.; Puntes, V. Distribution and Potential Toxicity of Engineered Inorganic Nanoparticles and Carbon Nanostructures in Biological Systems TrAC, Trends Anal. Chem. 2008, 27, 672-683
55. Poland, C. A.; Duffin, R.; Kinloch, I.; Maynard, A.; Wallace, W. A. H.; Seaton, A.; Stone, V.; Brown, S.; MacNee, W.; Donaldson, K. Carbon Nanotubes Introduced into the Abdominal Cavity of Mice Show Asbestos-like Pathogenicity in a Pilot Study Nat. Nanotechnol. 2008, 3, 423-428
56. Goy-Lopez, S.; Juarez, J.; Alatorre-Meda, M.; Casals, E.; Puntes, V. F.; Taboada, P.; Mosquera, V. Physicochemical Characteristics of Protein-NP Bioconjugates: The Role of Particle Curvature and Solution Conditions on Human Serum Albumin Conformation and Fibrillogenesis Inhibition Langmuir 2012, 28, 9113-9126
57. Comenge, J.; Sotelo, C.; Romero, F.; Gallego, O.; Barnadas, A.; Parada, T. G. C.; Dominguez, F.; Puntes, V. F. Detoxifying Antitumoral Drugs via Nanoconjugation: The Case of Gold Nanoparticles and Cisplatin PLoS One 2012, 7, 16
58. Tenzer, S.; Docter, D.; Kuharev, J.; Musyanovych, A.; Fetz, V.; Hecht, R.; Schlenk, F.; Fischer, D.; Kiouptsi, K.; Reinhardt, C. et al. Rapid Formation of Plasma Protein Corona Critically Affects Nanoparticle Pathophysiology Nat. Nanotechnol. 2013, 8, 772-781
59. Salvati, A.; Pitek, A. S.; Monopoli, M. P.; Prapainop, K.; Bombelli, F. B.; Hristov, D. R.; Kelly, P. M.; Aberg, C.; Mahon, E.; Dawson, K. A. Transferrin-Functionalized Nanoparticles Lose Their Targeting Capabilities When a Biomolecule Corona Adsorbs on the Surface Nat. Nanotechnol. 2013, 8, 137-143
60. Maiorano, G.; Sabella, S.; Sorce, B.; Brunetti, V.; Malvindi, M. A.; Cingolani, R.; Pompa, P. P. Effects of Cell Culture Media on the Dynamic Formation of Protein-Nanoparticle Complexes and Influence on the Cellular Response ACS Nano 2010, 4, 7481-7491
61. Hamad, I.; Al-Hanbali, O.; Hunter, A. C.; Rutt, K. J.; Andresen, T. L.; Moghimi, S. M. Distinct Polymer Architecture Mediates Switching of Complement Activation Pathways at the Nanosphere-Serum Interface: Implications for Stealth Nanoparticle Engineering ACS Nano 2010, 4, 6629-6638
62. Sim, R. B.; Wallis, R. Surface Properties: Immune Attack on Nanoparticles Nat. Nanotechnol. 2011, 6, 80-81
63. Nel, A. E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M. V.; Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, M. Understanding Biophysicochemical Interactions at the Nano-Bio Interface Nat. Mater. 2009, 8, 543-557
64. Bhattacharyya, S.; Bhattacharya, R.; Curley, S.; McNiven, M. A.; Mukherjee, P. Nanoconjugation Modulates the Trafficking and Mechanism of Antibody Induced Receptor Endocytosis Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 14541-14546
65. Deng, Z. J.; Liang, M. T.; Monteiro, M.; Toth, I.; Minchin, R. F. Nanoparticle-Induced Unfolding of Fibrinogen Promotes Mac-1 Receptor Activation and Inflammation Nat. Nanotechnol. 2011, 6, 39-44
66. Bastus, N. G.; Sanchez-Tillo, E.; Pujals, S.; Farrera, C.; Lopez, C.; Giralt, E.; Celada, A.; Lloberas, J.; Puntes, V. Homogeneous Conjugation of Peptides onto Gold Nanoparticles Enhances Macrophage Response ACS Nano 2009, 3, 1335-1344
67. Choi, H. S.; Liu, W.; Misra, P.; Tanaka, E.; Zimmer, J. P.; Ipe, B. I.; Bawendi, M. G.; Frangioni, J. V. Renal Clearance of Quantum Dots Nat. Biotechnol. 2007, 25, 1165-1170
68. Choi, H. S.; Liu, W. H.; Liu, F. B.; Nasr, K.; Misra, P.; Bawendi, M. G.; Frangioni, J. V. Design Considerations for Tumour-Targeted Nanoparticles Nat. Nanotechnol. 2010, 5, 42-47
69. Chanan-Khan, A.; Szebeni, J.; Savay, S.; Liebes, L.; Rafique, N. M.; Alving, C. R.; Muggia, F. M. Complement Activation Following First Exposure to PEGylated Liposomal Doxorubicin (Doxil): Possible Role in Hypersensitivity Reactions Ann. Oncol. 2003, 14, 1430-1437
70. Szebeni, J. Complement Activation-Related Pseudoallergy: A New Class of Drug-Induced Acute Immune Toxicity Toxicology 2005, 216, 106-121
71. Knop, K.; Hoogenboom, R.; Fischer, D.; Schubert, U. S. Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives Angew. Chem., Int. Ed. 2010, 49, 6288-6308
72. Pelaz, B.; Jaber, S.; de Aberasturi, D. J.; Wulf, V.; Aida, T.; de la Fuente, J. M.; Feldmann, J.; Gaub, H. E.; Josephson, L.; Kagan, C. R. et al. The State of Nanoparticle-Based Nanoscience and Biotechnology: Progress, Promises, and Challenges ACS Nano 2012, 6, 8468-8483
73. Lee, S. H.; Castagner, B.; Leroux, J. C. Is There a Future for Cell-Penetrating Peptides in Oligonucleotide Delivery? Eur. J. Pharm. Biopharm. 2013, 85, 5-11
74. Bechara, C.; Sagan, S. Cell-Penetrating Peptides: 20 Years Later, Where Do We Stand? FEBS Lett. 2013, 587, 1693-1702
75. Iversen, T.-G.; Skotland, T.; Sandvig, K. Endocytosis and Intracellular Transport of Nanoparticles: Present Knowledge and Need for Future Studies Nano Today 2011, 6, 176-185
76. Verma, A.; Uzun, O.; Hu, Y.; Hu, Y.; Han, H.-S.; Watson, N.; Chen, S.; Irvine, D. J.; Stellacci, F. Surface-Structure-Regulated Cell-Membrane Penetration by Monolayer-Protected Nanoparticles Nat. Mater. 2013, 12, 376-376
77. Gilleron, J.; Querbes, W.; Zeigerer, A.; Borodovsky, A.; Marsico, G.; Schubert, U.; Manygoats, K.; Seifert, S.; Andree, C.; Stoeter, M. et al. Image-Based Analysis of Lipid Nanoparticle-Mediated siRNA Delivery, Intracellular Trafficking and Endosomal Escape Nat. Biotechnol. 2013, 31, 638-646
78. Sahay, G.; Querbes, W.; Alabi, C.; Eltoukhy, A.; Sarkar, S.; Zurenko, C.; Karagiannis, E.; Love, K.; Chen, D.; Zoncu, R. et al. Efficiency of siRNA Delivery by Lipid Nanoparticles Is Limited by Endocytic Recycling Nat. Biotechnol. 2013, 31, 653-658
79. Marsico, G. Response to comment on Gilleron et al. In PubPeer, http://pubpeer.com/publications/BECD9A153DB5564060F49D684588B4/comments/2063, n.d., Retrieved October 8, 2013.
80. Li, Y.; Li, X.; Li, Z.; Gao, H. Surface-Structure-Regulated Penetration of Nanoparticles Across a Cell Membrane Nanoscale 2012, 4, 3768-3775
81. Gkeka, P.; Sarkisov, L.; Angelikopoulos, P. Homogeneous Hydrophobic-Hydrophilic Surface Patterns Enhance Permeation of Nanoparticles through Lipid Membranes J. Phys. Chem. Lett. 2013, 4, 1907-1912
82. Schulz, M.; Olubummo, A.; Binder, W. H. Beyond the Lipid-Bilayer: Interaction of Polymers and Nanoparticles with Membranes Soft Matter 2012, 8, 4849-4864
83. Binks, B. P. Particles as Surfactants-Similarities and Differences Curr. Opin. Colloid Interface Sci. 2002, 7, 21-41
84. Baronzio, G. F.; Hager, E. D. Hyperthermia in Cancer Treatment: A Primer; Landes Bioscience and Springer Science+Business Media, LLC: New York, 2006.
85. Song, C. W. Effect of Local Hyperthermia on Blood Flow and Microenvironment. A Review Cancer Res. 1984, 44, 4721S-4730S
86. Huang, X. H.; El-Sayed, I. H.; Qian, W.; El-Sayed, M. A. Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods J. Am. Chem. Soc. 2006, 128, 2115-2120
87. Hirsch, L. R.; Stafford, R. J.; Bankson, J. A.; Sershen, S. R.; Rivera, B.; Price, R. E.; Hazle, J. D.; Halas, N. J.; West, J. L. Nanoshell-Mediated Near-Infrared Thermal Therapy of Tumors under Magnetic Resonance Guidance Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 13549-13554
88. Bardhan, R.; Lal, S.; Joshi, A.; Halas, N. J. Theranostic Nanoshells: From Probe Design to Imaging and Treatment of Cancer Acc. Chem. Res. 2011, 44, 936-946
89. Goya, G. F.; Asin, L.; Ibarra, M. R. Cell Death Induced by AC Magnetic Fields and Magnetic Nanoparticles: Current State and Perspectives Int. J. Hyperthermia 2013, 29, 810-818
90. Creixell, M.; Bohorquez, A. C.; Torres-Lugo, M.; Rinaldi, C. EGFR-Targeted Magnetic Nanoparticle Heaters Kill Cancer Cells without a Perceptible Temperature Rise ACS Nano 2011, 5, 7124-7129
91. N'Guyen, T. T. T.; Duong, H. T. T.; Basuki, J.; Montembault, V.; Pascual, S.; Guibert, C.; Fresnais, J.; Boyer, C.; Whittaker, M. R.; Davis, T. P. et al. Functional Iron Oxide Magnetic Nanoparticles with Hyperthermia-Induced Drug Release Ability by Using a Combination of Orthogonal Click Reactions Angew. Chem., Int. Ed. 2013, 52, 14152-14156
92. Riedinger, A.; Guardia, P.; Curcio, A.; Garcia, M. A.; Cingolani, R.; Manna, L.; Pellegrino, T. Subnanometer Local Temperature Probing and Remotely Controlled Drug Release Based on Azo-Functionalized Iron Oxide Nanoparticles Nano Lett. 2013, 13, 2399-2406
93. Yoo, D.; Jeong, H.; Noh, S. H.; Lee, J. H.; Cheon, J. Magnetically Triggered Dual Functional Nanoparticles for Resistance-Free Apoptotic Hyperthermia Angew. Chem., Int. Ed. 2013, 52, 13047-13051
94. Dias, J. T.; Moros, M.; Del Pino, P.; Rivera, S.; Grazu, V.; de la Fuente, J. M. DNA as a Molecular Local Thermal Probe for the Analysis of Magnetic Hyperthermia Angew. Chem., Int. Ed. 2013, 52, 11526-11529
95. Hergt, R.; Dutz, S. Magnetic Particle Hyperthermia: Biophysical Limitations of a Visionary Tumour Therapy J. Magn. Magn. Mater. 2007, 311, 187-192
96. Li, T. J.; Huang, C. C.; Ruan, P. W.; Chuang, K. Y.; Huang, K. J.; Shieh, D. B.; Yeh, C. S. In Vivo Anti-cancer Efficacy of Magnetite Nanocrystal-Based System Using Locoregional Hyperthermia Combined with 5-Fluorouracil Chemotherapy Biomaterials 2013, 34, 7873-7883
97. Derfus, A. M.; von Maltzahn, G.; Harris, T. J.; Duza, T.; Vecchio, K. S.; Ruoslahti, E.; Bhatia, S. N. Remotely Triggered Release from Magnetic Nanoparticles Adv. Mater. 2007, 19, 3932-3936
98. Maier-Hauff, K.; Rothe, R.; Scholz, R.; Gneveckow, U.; Wust, P.; Thiesen, B.; Feussner, A.; von Deimling, A.; Waldoefner, N.; Felix, R. et al. Intracranial Thermotherapy Using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme J. Neuro-Oncol. 2007, 81, 53-60
99. Thiesen, B.; Jordan, A. Clinical Applications of Magnetic Nanoparticles for Hyperthermia Int. J. Hyperthermia 2008, 24, 467-474
100. Liu, J.; Detrembleur, C.; De Pauw-Gillet, M. C.; Mornet, S.; Vander Elst, L.; Laurent, S.; Jerome, C.; Duguet, E. Heat-Triggered Drug Release Systems Based on Mesoporous Silica Nanoparticles Filled with a Maghemite Core and Phase-Change Molecules as Gatekeepers J. Mater. Chem. B 2014, 2, 59-70
101. Lee, J. H.; Chen, K. J.; Noh, S. H.; Garcia, M. A.; Wang, H.; Lin, W. Y.; Jeong, H.; Kong, B. J.; Stout, D. B.; Cheon, J. et al. On-Demand Drug Release System for In Vivo Cancer Treatment through Self-Assembled Magnetic Nanoparticles Angew. Chem., Int. Ed. 2013, 52, 4384-4388
102. Ruiz-Hernandez, E.; Baeza, A.; Vallet-Regi, M. Smart Drug Delivery through DNA/Magnetic Nanoparticle Gates ACS Nano 2011, 5, 1259-1266
103. 4 Nanoparticles for Targeted Delivery and Controlled Release of Cisplatin J. Am. Chem. Soc. 2009, 131, 10637-10644
104. George, C.; Dorfs, D.; Bertoni, G.; Falqui, A.; Genovese, A.; Pellegrino, T.; Roig, A.; Quarta, A.; Comparelli, R.; Curri, M. L. et al. A Cast-Mold Approach to Iron Oxide and Pt/Iron Oxide Nanocontainers and Nanoparticles with a Reactive Concave Surface J. Am. Chem. Soc. 2011, 133, 2205-2217
105. Shin, J. M.; Anisur, R. M.; Ko, M. K.; Im, G. H.; Lee, J. H.; Lee, I. S. Hollow Manganese Oxide Nanoparticles as Multifunctional Agents for Magnetic Resonance Imaging and Drug Delivery Angew. Chem., Int. Ed. 2009, 48, 321-324
106. Liu, H. L.; Hua, M. Y.; Yang, H. W.; Huang, C. Y.; Chu, P. C.; Wu, J. S.; Tseng, I. C.; Wang, J. J.; Yen, T. C.; Chen, P. Y. et al. Magnetic Resonance Monitoring of Focused Ultrasound/Magnetic Nanoparticle Targeting Delivery of Therapeutic Agents to the Brain Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 15205-15210
107. Gao, J. H.; Liang, G. L.; Cheung, J. S.; Pan, Y.; Kuang, Y.; Zhao, F.; Zhang, B.; Zhang, X. X.; Wu, E. X.; Xu, B. Multifunctional Yolk-Shell Nanoparticles: A Potential MRI Contrast and Anticancer Agent J. Am. Chem. Soc. 2008, 130, 11828-11833
108. 2 Yolk-Shell Nanocrystals as a Potent Agent To Kill HeLa Cells J. Am. Chem. Soc. 2007, 129, 1428-1433
109. Lartigue, L.; Alloyeau, D.; Kolosnjaj-Tabi, J.; Javed, Y.; Guardia, P.; Riedinger, A.; Pechoux, C.; Pellegrino, T.; Wilhelm, C.; Gazeaut, F. Biodegradation of Iron Oxide Nanocubes: High-Resolution In Situ Monitoring ACS Nano 2013, 7, 3939-3952
110. Landesman-Milo, D.; Peer, D. Altering the Immune Response with Lipid-Based Nanoparticles J. Controlled Release 2012, 161, 600-608
111. Peer, D. Immunotoxicity Derived from Manipulating Leukocytes with Lipid-Based Nanoparticles Adv. Drug Delivery Rev. 2012, 64, 1738-1748
112. Szebeni, J.; Moghimi, S. M. Liposome Triggering of Innate Immune Responses: A Perspective on Benefits and Adverse Reactions J. Liposome Res. 2009, 19, 85-90
113. Szebeni, J.; Muggia, F.; Gabizon, A.; Barenholz, Y. Activation of Complement by Therapeutic Liposomes and Other Lipid Excipient-Based Therapeutic Products: Prediction and Prevention Adv. Drug Delivery Rev. 2011, 63, 1020-1030
114. Landesman-Milo, D.; Peer, D. Altering the Immune Response with Lipid-Based Nanoparticles J. Controlled Release 2012, 161, 600-608
115. Haber, E.; Afergan, E.; Epstein, H.; Gutman, D.; Koroukhov, N.; Ben-David, M.; Schachter, M.; Golomb, G. Route of Administration-Dependent Anti-inflammatory Effect of Liposomal Alendronate J. Controlled Release 2010, 148, 226-233
116. Kedmi, R.; Ben-Arie, N.; Peer, D. The Systemic Toxicity of Positively Charged Lipid Nanoparticles and the Role of Toll-like Receptor 4 in Immune Activation Biomaterials 2010, 31, 6867-6875
117. Lonez, C.; Lensink, M. F.; Vandenbranden, M.; Ruysschaert, J. M. Cationic Lipids Activate Cellular Cascades. Which Receptors Are Involved? Biochim. Biophys. Acta 2009, 1790, 425-430
118. Moghimi, S. M.; Peer, D.; Langer, R. Reshaping the Future of Nanopharmaceuticals ad Ludicium ACS Nano 2011, 5, 8454-8458
119. Moghimi, S. M.; Hunter, A. C. Recognition by Macrophages and Liver Cells of Opsonized Phospholipid Vesicles and Phospholipid Headgroups Pharm. Res. 2001, 18, 1-8
120. Goldsmith, M.; Mizrahy, S.; Peer, D. Grand Challenges in Modulating the Immune Response with RNAi Nanomedicines Nanomedicine 2011, 6, 1771-1785
121. Zolnik, B. S.; Gonzalez-Fernandez, A.; Sadrieh, N.; Dobrovolskaia, M. A. Nanoparticles and the Immune System Endocrinology 2010, 151, 458-465
122. Szebeni, J.; Alving, C. R.; Rosivall, L.; Bunger, R.; Baranyi, L.; Bedocs, P.; Toth, M.; Barenholz, Y. Animal Models of Complement-Mediated Hypersensitivity Reactions to Liposomes and Other Lipid-Based Nanoparticles J. Liposome Res. 2007, 17, 107-117
123. Chanan-Khan, A.; Szebeni, J.; Savay, S.; Liebes, L.; Rafique, N. M.; Alving, C. R.; Muggia, F. M. Complement Activation Following First Exposure to PEGylated Liposomal Doxorubicin (Doxil): Possible Role in Hypersensitivity Reactions Ann. Oncol. 2003, 14, 1430-1437
124. Szebeni, J.; Baranyi, L.; Savay, S.; Milosevits, J.; Bunger, R.; Laverman, P.; Metselaar, J. M.; Storm, G.; Chanan-Khan, A.; Liebes, L. et al. Role of Complement Activation in Hypersensitivity Reactions to Doxil and Hynic PEG Liposomes: Experimental and Clinical Studies J. Liposome Res. 2002, 12, 165-172
125. Matsumura, Y.; Maeda, H. A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs Cancer Res. 1986, 46, 6387-6392
126. Prabhakar, U.; Maeda, H.; Jain, R. K.; Sevick-Muraca, E. M.; Zamboni, W.; Farokhzad, O. C.; Barry, S. T.; Gabizon, A.; Grodzinski, P.; Blakey, D. C. Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology Cancer Res. 2013, 73, 2412-2417
127. Maeda, H.; Nakamura, H.; Fang, J. The EPR Effect for Macromolecular Drug Delivery to Solid Tumors: Improvement of Tumor Uptake, Lowering of Systemic Toxicity, and Distinct Tumor Imaging in Vivo Adv. Drug Delivery Rev. 2013, 65, 71-79
128. Howard, K. A.; Peer, D. Providing the Full Picture: A Mandate for Standardizing Nanoparticle-Based Drug Delivery Nanomedicine 2013, 8, 1031-1033
129. Harrington, K. J.; Mohammadtaghi, S.; Uster, P. S.; Glass, D.; Peters, A. M.; Vile, R. G.; Stewart, J. S. Effective Targeting of Solid Tumors in Patients with Locally Advanced Cancers by Radiolabeled PEGylated Liposomes Clin. Cancer Res. 2001, 7, 243-254
130. Peer, D.; Karp, J. M.; Hong, S.; FaroKhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760
131. Davis, M. E.; Zuckerman, J. E.; Choi, C. H.; Seligson, D.; Tolcher, A.; Alabi, C. A.; Yen, Y.; Heidel, J. D.; Ribas, A. Evidence of RNAi in Humans from Systemically Administered siRNA via Targeted Nanoparticles Nature 2010, 464, 1067-1070
132. Hrkach, J.; Von Hoff, D.; Mukkaram Ali, M.; Andrianova, E.; Auer, J.; Campbell, T.; De Witt, D.; Figa, M.; Figueiredo, M.; Horhota, A. et al. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile Sci. Transl. Med. 2012, 4, 128ra39
133. Peer, D.; Park, E. J.; Morishita, Y.; Carman, C. V.; Shimaoka, M. Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-inflammatory Target Science 2008, 319, 627-630
134. Elinav, E.; Peer, D. Harnessing Nanomedicine for Mucosal Theranostics-A Silver Bullet at Last? ACS Nano 2013, 7, 2883-2890